Skip to content

Use of local anaesthetic for Quadratus Lumborum muscle Block in patients undergoing surgical removal of uterus and its effect on requirement of post operative pain relief medications

Comparison of ultrasound guided Quadratus Lumborum Block with intravenous patient controlled analgesia in patients undergoing Total Abdominal Hysterectomy

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/02/007905
Enrollment
90
Registered
2017-02-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patients undergoing Total Abdominal Hysterectomy Health Condition 2: N949- Unspecified condition associated with female genital organs and menstrual cycle

Interventions

Intervention1: Group Q- patients will receive bilateral quadratus lumborum Block with 0.2% Ropivacaine along with intravenous patient controlled analgesia. : patients will receive ultrasound guided bi

Sponsors

Department of Anaesthesia and Intensive Care
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Females suffering from pathology requiring total abdominal hysterectomy 2. American Society of Anesthesiologists physical status I-II

Exclusion criteria

Exclusion criteria: 1. History of relevant drug allergy 2. History of psychiatric illness, substance abuse 3. Severe cardiovascular, respiratory, liver diseases metabolic or neurological disease 4. Chronic treatment with analgesics 5.Coagulopathy 6.Infection at planned injection site 7.Psychological inability of the patient to understand visual analogue scale 8.History of intake of drugs such as imipramine, theophylline, fluvoxamine and antiarrhythmic agents

Design outcomes

Primary

MeasureTime frame
To analyze the intensity of post-operative pain relief in both groups by visual analogue scaleTimepoint: 30mins, 1hr, 4hrs, 8hrs, 12hrs, 24hrs, 36hrs and 48 hrs.

Secondary

MeasureTime frame
To analyze total cumulative morphine consumption in both the groups over 48 hoursTimepoint: 30mins, 1hr, 4hrs, 8hrs, 12hrs, 24hrs, 36hrs and 48 hrs.

Countries

India

Contacts

Public ContactDr Tanvi Khera

Government Medical College and Hospital Chandigarh

sanjeev_palta@yahoo.com9646121523

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026